newsfilter
← Latest News
GlobeNewswire·

La Jolla to Reassess Continued Development of LJPC-401 Based on Recent Clinical Results

SAN DIEGO, Nov. 25, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to...